Literature DB >> 9250603

Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport.

Z Sfeir1, A Ibrahimi, E Amri, P Grimaldi, N Abumrad.   

Abstract

Much biochemical evidence has implicated rat adipocyte CD36 (FAT) in membrane binding and transport of long-chain fatty acids (FA). Expression of the mRNA favored tissues with active FA metabolism and was upregulated in vivo with diabetes and with high fat feeding. In culture, CD36 mRNA was a strong marker of preadipocyte differentiation and was modulated by the same factors effective on mRNAs coding for other proteins involved in FA metabolism. In preadipocytes, long-chain FA or 2-bromopalmitate but not short-chain FA strongly induced CD36 mRNA within 8 h to an optimum within 24 h. Removal of the FA resulted in a decay of CD36 mRNA with a half life of about 12 h. In differentiated adipocytes, levels of CD36 mRNA were downregulated by the 3': 5'-cyclic adenosine monophosphate, cAMP, analog, 8-(4-chlorophenylthio) adenosine, 8-CPT, at concentrations of 1-100 microM. The effect, observed within 6 h, was optimal after 18 h and independent of the action of 8-CPT to mobilize FA. Regulation of CD36 expression by factors effective on expression of other proteins implicated in FA metabolism is consistent with its role in membrane FA transport.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250603     DOI: 10.1016/s0952-3278(97)90487-7

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  26 in total

Review 1.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

Review 3.  CD36: implications in cardiovascular disease.

Authors:  Maria Febbraio; Roy L Silverstein
Journal:  Int J Biochem Cell Biol       Date:  2007-03-23       Impact factor: 5.085

Review 4.  The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36.

Authors:  M Febbraio; E Guy; C Coburn; F F Knapp; A L Beets; N A Abumrad; R L Silverstein
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

5.  The role of hyperglycemia in FAT/CD36 expression and function.

Authors:  Min Chen; Ying-Kui Yang; Tara J Loux; Keith E Georgeson; Carroll M Harmon
Journal:  Pediatr Surg Int       Date:  2006-07-13       Impact factor: 1.827

6.  CD36 antisense expression in 3T3-F442A preadipocytes.

Authors:  Z Sfeir; A Ibrahimi; E Amri; P Grimaldi; N Abumrad
Journal:  Mol Cell Biochem       Date:  1999-02       Impact factor: 3.396

7.  Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin.

Authors:  Jiong Zhao; Xue-Bing Sun; Fei Ye; Wei-Xi Tian
Journal:  Mol Cell Biochem       Date:  2011-01-09       Impact factor: 3.396

8.  Molecular cloning and gene/protein expression of FAT/CD36 from grass carp (Ctenopharyngodon idella) and the regulation of its expression by dietary energy.

Authors:  Juan Tian; Wei Liu; Weihua Gao; Fan Wu; Lijuan Yu; Xing Lu; Chang-Geng Yang; Ming Jiang; Hua Wen
Journal:  Fish Physiol Biochem       Date:  2017-01-18       Impact factor: 2.794

Review 9.  PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Nucl Recept Signal       Date:  2010-04-16

Review 10.  Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification.

Authors:  Paul N Black; Concetta C DiRusso
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.